- Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial
-
Choi KH, Chung WC, Lee KM, Paik CN, Kim EJ, Kang BK, Oak JH, Jung SH
- KMID: 1785965
- J Korean Med Sci.
- 2011 Jun;26(6):785-790.
- doi: 10.3346/jkms.2011.26.6.785
The aim of this study was to evaluate the efficacy of levofloxacin and rifaximin based quadruple regimen as first-line treatment for Helicobacter pylori infection. A prospectively randomized, double-blinded, parallel group,... -
- CITED
-
- Close
- SHARE
-
- Close
- Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects
-
Bae S, Lee KJ, Kim YS, Kim KN
- KMID: 2160605
- J Korean Med Sci.
- 2015 Jun;30(6):757-762.
- doi: 10.3346/jkms.2015.30.6.757
Small intestinal bacterial overgrowth (SIBO) can partly explain irritable bowel syndrome (IBS), and rifaximin has been observed to improve abdominal symptoms in nonconstipated IBS patients. However, there are few reports... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Rifaximin and Lactulose for the Treatment of Hepatic Encephalopathy: A Prospective Randomized Study
-
Paik YH, Lee KS, Han KH, Song KH, Kim MH, Moon BS, Ahn SH, Lee SJ, Park HJ, Lee DK, Chon CY, Lee SI, Moon YM
- KMID: 1734076
- Yonsei Med J.
- 2005 Jun;46(3):399-407.
- doi: 10.3349/ymj.2005.46.3.399
Rifaximin has been reported to be effective for the treatment of hepatic encephalopathy (HE) in Europe. However, it is unknown whether Rifaximin is effective for the treatment of HE in... -
- CITED
-
- Close
- SHARE
-
- Close
